Free Online Panel Discussion | Compliance Without Compromise: Why Modern Labs Are Moving Past Legacy LIMS

David Joyce Director of Product Management – Digital Science Solutions Thermo Fisher Scientific

David Joyce is the Director of Product Management for Thermo Scientific Watson LIMS software at Thermo Fisher Scientific. David (also known as DJ) has 24 years of experience in the LIMS industry, has worked at Thermo Fisher for the last 20 years, and spent the last 5.5 of that Thermo Fisher’s Digital Science Solutions business. He is responsible for the development and innovation around our Watson LIMS software, creating successful and innovative product enhancements to serve our customers needs. DJ has been involved in numerous implementations, across a variety of industries, including bioanalysis. As a product manager he has experience with middleware, SDMS, Instrument Control, Cloud Based Spectral Search, and SAP Connectivity. DJ graduated from the University of Nottingham with a Bachelor of Science in Biochemistry and Genetics.
 

Stephanie Pasas-Farmer, PhD Founder and President BioData Solutions Consulting and Software

Stephanie Pasas-Farmer, PhD is a recognised bioanalytical expert in the areas of discovery and regulated bioanalysis for pharmaceutical, biologics, and hybrid technologies, including antibody-drug conjugate technology. Relying on insights gained over a 20-year career focused on bioanalytical operations across global biopharmaceutical companies, contract research organisations and consulting, Stephanie founded Ariadne Software in 2018 and led development of Red Thread, guiding it from inception to production as an artificial intelligence (AI)-enabled solution for common challenges in bioanalytical data review. Prior to Ariadne Software, Stephanie created BioData Solutions, a scientific advisor firm whose aim is to help sponsors advance early-stage molecules into potential new drug candidates with bioanalysis support and regulatory compliance planning. Before founding BioData Solutions, she led a team of scientists at a global bioanalytical laboratory focused on the support of large molecule and antibody drug conjugate programs using LBA, LC-MS/MS, and cell-based assays. Stephanie earned her PhD and MSc degrees with honours in pharmaceutical chemistry from the University of Kansas. She received a BS degree in chemistry from St. Mary’s College of Notre Dame. 
 

Dr Bob McDowall Director R D McDowall Ltd

Bob McDowall has been an analytical chemist for over 50 years; an independent consultant for over 32 years, six years as a forensic toxicologist and 15 years working in the pharmaceutical industry for two major international companies. Bob has over 40 years of experience with specifying, implementing and validating LIMS; he edited the first book on LIMS in 1987 and is the 1997 LIMS Awardee. He writes the Questions of Quality and Focus on Quality columns in LCGC International and Spectroscopy magazines, respectively. Bob consults and trains on digitalisation, data integrity and computerised system validation for regulated GXP laboratories, and is also a trained auditor. Additionally, he was the only European co-chair of the 1990 FDA-AAPS bioanalytical methods validation conference and subsequent reports published in scientific journals.